Short Interest in Verona Pharma plc (NASDAQ:TARA) Grows By 400.0%

Share on StockTwits

Verona Pharma plc (NASDAQ:TARA) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totalling 4,000 shares, an increase of 400.0% from the February 27th total of 800 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an average daily volume of 9,800 shares, the days-to-cover ratio is currently 0.4 days.

An institutional investor recently bought a new position in Verona Pharma stock. Victory Capital Management Inc. bought a new position in Verona Pharma plc (NASDAQ:TARA) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 992 shares of the company’s stock, valued at approximately $32,000. Victory Capital Management Inc. owned 0.18% of Verona Pharma as of its most recent SEC filing.

TARA opened at $22.01 on Friday. The company has a market cap of $140.23 million, a price-to-earnings ratio of -0.57 and a beta of 0.58. The stock’s fifty day moving average is $29.97. Verona Pharma has a fifty-two week low of $8.80 and a fifty-two week high of $152.40.

Several equities analysts have recently issued reports on TARA shares. LADENBURG THALM/SH SH started coverage on Verona Pharma in a research report on Wednesday, January 22nd. They set a “buy” rating and a $45.00 price target on the stock. ValuEngine upgraded Verona Pharma from a “hold” rating to a “buy” rating in a research report on Tuesday, February 4th.

Verona Pharma Company Profile

ArTara Therapeutics, Inc develops rare diseases therapeutics for patients suffering from gastrointestinal, metabolic, circulatory, and neurological disorders. It offers IV Choline Chloride, a drug for the orphan disease intestinal failure associated liver disease (IFALD). The company was incorporated in 2017 and is headquartered in New York, New York.

Featured Article: Profit margin is different from the revenue

Receive News & Ratings for Verona Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Mitchell Mcleod Pugh & Williams Inc. Has $252,000 Holdings in General Electric
Mitchell Mcleod Pugh & Williams Inc. Has $252,000 Holdings in General Electric
Mitchell Mcleod Pugh & Williams Inc. Acquires 500 Shares of Starbucks Co.
Mitchell Mcleod Pugh & Williams Inc. Acquires 500 Shares of Starbucks Co.
Bank of America  PT Lowered to $20.00 at UBS Group
Bank of America PT Lowered to $20.00 at UBS Group
IFM Investors Pty Ltd Sells 5,253 Shares of Walmart Inc
IFM Investors Pty Ltd Sells 5,253 Shares of Walmart Inc
Macquarie Group Ltd. Has $2.83 Million Position in Valero Energy Co.
Macquarie Group Ltd. Has $2.83 Million Position in Valero Energy Co.
Marquette Asset Management LLC Increases Stock Position in Boeing Co
Marquette Asset Management LLC Increases Stock Position in Boeing Co


© 2006-2020 Ticker Report